dactinomycin has been researched along with Critical Illness in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HW; Chang, YT; Cheng, BC; Cheng, HH; Chiang, YF; Hsiao, SY; Kung, CT; Lin, WC; Lu, CH; Su, CM; Su, YJ; Tsai, NW; Tsai, TC; Wang, HC | 1 |
Graubner, U; Hauer, J; Konstantopoulos, N; Pfluger, T; Schmid, I; Schmidt, S | 1 |
2 other study(ies) available for dactinomycin and Critical Illness
Article | Year |
---|---|
The prognostic value of leukocyte apoptosis in patients with severe sepsis at the emergency department.
Topics: Aged; Aged, 80 and over; Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Bacterial Infections; Case-Control Studies; Cells, Cultured; Critical Illness; Dactinomycin; Emergency Service, Hospital; Female; Flow Cytometry; Fluorescent Dyes; Humans; Lactic Acid; Leukocytes; Male; Middle Aged; Mitochondrial Proteins; Monocytes; Prognosis; Prospective Studies; Sepsis; Survival Analysis | 2015 |
Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cortisone; Critical Illness; Cyclophosphamide; Dactinomycin; Female; Hemangioendothelioma; Humans; Infant; Interferon-alpha; Methotrexate; Remission Induction; Thoracic Neoplasms; Vincristine | 2007 |